137 related articles for article (PubMed ID: 8456437)
1. Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis.
Dickneite G; Pâques EP
Thromb Haemost; 1993 Feb; 69(2):98-102. PubMed ID: 8456437
[TBL] [Abstract][Full Text] [Related]
2. Combination of antibiotic treatment with the thrombin inhibitor recombinant hirudin for the therapy of experimental Klebsiella pneumoniae sepsis.
Dickneite G; Czech J
Thromb Haemost; 1994 Jun; 71(6):768-72. PubMed ID: 7974345
[TBL] [Abstract][Full Text] [Related]
3. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats.
Bahrami S; Paul E; Redl H; Schlag G
Prog Clin Biol Res; 1989; 308():977-82. PubMed ID: 2780743
[No Abstract] [Full Text] [Related]
5. [Treatment effects of antithrombin-III on coagulation abnormalities in rats with endotoxaemia].
Qiao YJ; Zhu JM; You XL; Zhang Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):165-7. PubMed ID: 17376272
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models.
Asakura H; Aoshima K; Suga Y; Yamazaki M; Morishita E; Saito M; Miyamoto K; Nakao S
Thromb Haemost; 2001 Feb; 85(2):287-90. PubMed ID: 11246549
[TBL] [Abstract][Full Text] [Related]
7. Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat.
Emerson TE; Fournel MA; Leach WJ; Redens TB
Circ Shock; 1987; 21(1):1-13. PubMed ID: 3545529
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation.
Hauptman JG; Hassouna HI; Bell TG; Penner JA; Emerson TE
Circ Shock; 1988 Jun; 25(2):111-22. PubMed ID: 3390893
[TBL] [Abstract][Full Text] [Related]
9. The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity.
Kessler CM; Tang Z; Jacobs HM; Szymanski LM
Blood; 1997 Jun; 89(12):4393-401. PubMed ID: 9192763
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
[TBL] [Abstract][Full Text] [Related]
11. Therapy of Klebsiella pneumoniae septicaemia in neutropenic rats.
Magliulo E; Piantieri G; Cafarelli A; Cruciani M
Pharmatherapeutica; 1982; 3(2):114-8. PubMed ID: 7048337
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin-III treatment limits disseminated intravascular coagulation in endotoxemia.
Redens TB; Emerson TE
Circ Shock; 1989 May; 28(1):49-58. PubMed ID: 2731321
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin III concentrate in the treatment of DIC: a retrospective follow-up study.
van Beek EJ; von der Möhlen MA; ten Cate JW; Brandjes DP; Büller HR
Neth J Med; 1994 Nov; 45(5):206-10. PubMed ID: 7830846
[TBL] [Abstract][Full Text] [Related]
14. Defective innate antibacterial host responses during murine Klebsiella pneumoniae bacteremia: tumor necrosis factor (TNF) receptor 1 deficiency versus therapy with anti-TNF-alpha.
Moore TA; Lau HY; Cogen AL; Standiford TJ
Clin Infect Dis; 2005 Aug; 41 Suppl 3():S213-7. PubMed ID: 15983903
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin M-enriched intravenous polyclonal immunoglobulins reduce bacteremia following Klebsiella pneumoniae infection in an acute respiratory distress syndrome rat model.
Lachmann RA; van Kaam AH; Haitsma JJ; Verbrugge SJ; Delreu F; Lachmann B
Exp Lung Res; 2004 Jun; 30(4):251-60. PubMed ID: 15204832
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
Hanada T; Abe T; Takita H
Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human antithrombin expressed in Chinese hamster ovary cells shows in vivo efficacy on rat DIC model similarly to plasma-derived antithrombin regardless of different N-glycosylation.
Hirose M; Tsukada M; Hirayama F; Kubo Y; Kajii M; Mochizuki S; Hamato N; Ohi H
Thromb Res; 2007; 119(5):631-41. PubMed ID: 16844203
[TBL] [Abstract][Full Text] [Related]
18. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
Aibiki M; Fukuoka N; Nishiyama T; Maekawa S; Shirakawa Y
Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammatory properties of antithrombin III: new therapeutic implications.
Okajima K; Uchiba M
Semin Thromb Hemost; 1998; 24(1):27-32. PubMed ID: 9515777
[TBL] [Abstract][Full Text] [Related]
20. [Phosphatidylcholine induces an increase in the production of interleukin-6 and improves survival of rats with neonatal sepsis caused by Klebsiella pneumoniae].
Mancilla-Ramírez J; Dinarello CA; Santos-Preciado JI
Gac Med Mex; 1995; 131(1):14-22. PubMed ID: 7493735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
